In a regulatory filing, Treace Medical (TMCI) disclosed that its CEO John Treace bought 60K shares of common stock on March 4th in a total transaction size of $524K. Shares of Treace Medical are up 4% afterhours at $9.20.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMCI:
Questions or Comments about the article? Write to editor@tipranks.com